ViGenCell Inc. (KOSDAQ:308080)
South Korea
· Delayed Price · Currency is KRW 11,070
-140 (-1.25%)
At close: Apr 28, 2026
ViGenCell Market Cap
ViGenCell has a market cap or net worth of 226.93 billion as of April 28, 2026. Its market cap has increased by 293.17% in one year.
Market Cap
226.93B
Enterprise Value
189.63B
Revenue
278.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
11,070.00
Market Cap Chart
Since August 25, 2021, ViGenCell's market cap has decreased from 561.23B to 226.93B, a decrease of -59.57%. That is a compound annual growth rate of -17.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 226.93B | 13.54% |
| Dec 30, 2025 | 199.87B | 315.01% |
| Dec 30, 2024 | 48.16B | -57.05% |
| Dec 28, 2023 | 112.12B | -17.15% |
| Dec 29, 2022 | 135.32B | -61.11% |
| Dec 30, 2021 | 347.95B | -38.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genome & Company | 221.57B |
| ABION | 236.52B |
| ISU Abxis | 201.00B |
| Ensol Biosciences | 186.26B |
| Prestige Biologics | 185.83B |
| Bio Solution | 295.98B |
| NIBEC | 309.20B |
| QuadMedicine | 164.54B |